High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: An anti-tumor effect of TLR5 signaling in non-small cell lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 4, 2014, Pages 633-643

  Zhou, Hui ^a,b   Chen, Jian Hua ^b   Hu, Jun ^b   Luo, Yong Zhong ^b   Li, Fang ^b   Xiao, Ling ^a,c   Zhong, Mei Zuo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Flagellin; Non small cell lung cancer; Prognosis; TLR5

Indexed keywords

BROXURIDINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FLAGELLIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 5;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BRDU INCORPORATION ASSAY; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOFT AGAR COLONY FORMATION ASSAY; TRANSWELL INVASION ASSAY; WESTERN BLOTTING; WOUND HEALING MIGRATION ASSAY;

ADENOCARCINOMA; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TOLL-LIKE RECEPTOR 5; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 84899493278     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1616-4     Document Type: Article

References (36)

1. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499-511. doi:10.1038/nri1391 (Pubitemid 38931765)
2. Badache A, Hynes NE (2001) Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res 61(1):383-391 (Pubitemid 32095742)
3. Barton GM, Medzhitov R (2002) Toll-like receptors and their ligands. Curr Top Microbiol Immunol 270:81-92 (Pubitemid 35448154)
4. Bill A, Schmitz A, Konig K, Heukamp LC, Hannam JS, Famulok M (2012) Anti-proliferative effect of cytohesin inhibition in gefitinib-resistant lung cancer cells. PLoS ONE 7(7):e41179. doi:10.1371/journal.pone.0041179
5. Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D (2011) Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 71(7):2466-2475. doi:10.1158/0008- 5472.CAN-10-1993
6. Carney DN (2002) Lung cancer-time to move on from chemotherapy. N Engl J Med 346(2):126-128. doi:10.1056/N EJM200201103460211
7. Cherfils-Vicini J, Platonova S, Gillard M, Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F, Dieu-Nosjean MC, Fridman WH, Damotte D, Sautes-Fridman C, Cremer I (2010) Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Investig 120(4):1285-1297. doi:10.1172/JCI36551
8. Du Y, Ma C, Wang Z, Liu Z, Liu H, Wang T (2013) Nanog, a novel prognostic marker for lung cancer. Surg Oncol. doi:10.1016/j.suronc.2013.08.001
9. Ellis PM, Vandermeer R (2011) Delays in the diagnosis of lung cancer. J Thorac Dis 3(3):183-188. doi:10.3978/j.issn.2072-1439.2011.01.01
10. Farjah F, Flum DR, Varghese TK Jr, Symons RG, Wood DE (2009) Surgeon specialty and long-term survival after pulmonary resection for lung cancer. Ann Thorac Surg 87(4):995-1004. doi:10.1016/j.athoracsur.2008.12.030; discussion 1005-1006
11. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315-2319. doi:10.1038/nprot.2006.339
12. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410(6832):1099-1103. doi:10.1038/35074106 (Pubitemid 32391041)
13. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408(6813):740-745. doi:10.1038/35047123 (Pubitemid 32015992)
14. Ishiguro H, Kishimoto T, Furuya M, Nagai Y, Watanabe T, Ishikura H (2005) Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts. Cancer Immunol Immunother 54(12):1191-1199. doi:10.1007/s00262-005-0695-0 (Pubitemid 41416951)
15. Iwamura C, Nakayama T (2008) Toll-like receptors in the respiratory system: their roles in inflammation. Curr Allergy Asthma Rep 8(1):7-13 (Pubitemid 351459687)
16. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57(1):43-66
17. Jiang BY, Zhang XC, Su J, Meng W, Yang XN, Yang JJ, Zhou Q, Chen ZY, Chen ZH, Xie Z, Chen SL, Wu YL (2013) BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification. Mol Cancer 12:61. doi:10.1186/1476-4598-12-61
18. Kauppila JH, Mattila AE, Karttunen TJ, Salo T (2013a) Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br J Cancer 108(3):638-643. doi:10.1038/bjc.2012.589
19. Kauppila JH, Mattila AE, Karttunen TJ, Salo T (2013b) Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis. Oncoimmunology 2(4):e23620. doi:10.4161/onci.23620
20. Kim WY, Lee JW, Choi JJ, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS (2008) Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 18(2):300-305. doi:10.1111/j.1525-1438.2007. 01008.x (Pubitemid 351365208)
21. Lin CY, Chuang TF, Liao KW, Huang YJ, Pai CC, Chu RM (2008) Combined immunogene therapy of IL-6 and IL-15 enhances antitumor activity through augmented NK cytotoxicity. Cancer Lett 272(2):285-295. doi:10.1016/j.canlet. 2008.07.016
22. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M (2009) Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 69(14):5893-5900. doi:10.1158/0008-5472.CAN-09-0755
23. Pimentel-Nunes P, Afonso L, Lopes P, Roncon-Albuquerque R Jr, Goncalves N, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M (2011) Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res 17(3):677-683. doi:10.1007/s12253-011-9368-9
24. Pinto A, Morello S, Sorrentino R (2011) Lung cancer and Toll-like receptors. Cancer Immunol Immunother 60(9):1211-1220. doi:10.1007/s00262-011- 1057-8
25. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396):2085-2088 (Pubitemid 29001265)
26. Rakoff-Nahoum S, Medzhitov R (2009) Toll-like receptors and cancer. Nat Rev Cancer 9(1):57-63. doi:10.1038/nrc2541
27. Rhee SH, Im E, Pothoulakis C (2008) Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology 135(2):518-528. doi:10.1053/j.gastro.2008.04.022
28. Rosell R, Bivona TG, Karachaliou N (2013) Genetics and biomarkers in personalisation of lung cancer treatment. Lancet 382(9893):720-731. doi:10.1016/S0140-6736(13)61715-8
29. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P (2009) The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 4(5):568-577. doi:10.1097/JTO.0b013e3181a0d82e
30. Samara KD, Antoniou KM, Karagiannis K, Margaritopoulos G, Lasithiotaki I, Koutala E, Siafakas NM (2012) Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol 40(5):1397-1404. doi:10.3892/ijo 2012.1374
31. Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Axel AE, Hall BM (2007) Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB J 21(13):3763-3770. doi:10.1096/fj.07-8832com (Pubitemid 350075164)
32. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805-820. doi:10.1016/j.cell.2010.01.022
33. Wang ZD, Qiao YL, Tian XF, Zhang XQ, Zhou SX, Liu HX, Chen Y (2012) Toll-like receptor 5 agonism protects mice from radiation pneumonitis and pulmonary fibrosis. Asian Pac J Cancer Prev 13(9):4763-4767
34. Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, Motohashi S, Yokoi S, Hiroshima K, Tagawa M, Nakayama T, Fujisawa T (2004) Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 53(9):786-792. doi:10.1007/s00262-004-0533-9 (Pubitemid 39149905)
35. Zhang J, Wu L, Qu JM (2011) Inhibited proliferation of human lung fibroblasts by LPS is through IL-6 and IL-8 release. Cytokine 54(3):289-295. doi:10.1016/j.cyto.2011.02.018
36. Zheng C, Sun YH, Ye XL, Chen HQ, Ji HB (2011) Establishment and characterization of primary lung cancer cell lines from Chinese population. Acta Pharmacol Sin 32(3):385-392. doi:10.1038/aps.2010.214